A Pilot Study to Investigate Biomarkers in Anterior Cruciate Ligament (ACL) Patients and Healthy Controls
1 other identifier
interventional
8
1 country
1
Brief Summary
Incident rates of ACL rupture are greatest in 16-39 year olds at almost 1 in 1,000. Performance Based Investigations (PBIs) can be used to evaluate and select correct approaches to patient treatment, and biochemical, biomechanical and physiological biomarkers in other conditions are sensitive in distinguishing between disease state severities, type of injuries and responsiveness to treatment. Despite the measurement sensitivity of PBIs, these are not widely used possibly owing to their focus postoperatively where benefits are less worthwhile. This study aims to investigate novel biomarkers as performance based investigations (PBIs) to improve surgical and treatment strategies in anterior cruciate ligament (ACL) patients. The objectives are to identify whether biomarkers, collected before and after operations, can: 1) Assist the surgeon in decision making; 2) Lead to improved prognosis; 3) Be used to predict the outcomes of prognosis, and; 4) Correlate with disease signs/ smoking to help further understand ACL injuries.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 23, 2014
CompletedFirst Posted
Study publicly available on registry
November 24, 2014
CompletedStudy Start
First participant enrolled
January 5, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 20, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 20, 2022
CompletedMay 27, 2022
May 1, 2022
7.4 years
October 23, 2014
May 23, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
The change in knee varus/valgus from baseline to 6 weeks post-ACL reconstruction, measured when performing a single leg squat.
Baseline, 6 weeks
The change in knee varus/valgus from baseline to 6 months post-ACL reconstruction, measured when performing a single leg squat
Baseline, 6 months
The change in peak vertical ground reaction force from baseline to 6 weeks post-ACL reconstruction, measured when performing a novel isometric task during sitting.
Baseline, 6 weeks
The change in peak vertical ground reaction force from baseline to 6 months post-ACL reconstruction, measured when performing a novel isometric task during sitting.
Baseline, 6 months
The change in anterior-posterior centre of pressure displacement from baseline to 6 weeks post-ACL reconstruction, measured when performing a 10 second standing balance task.
Baseline, 6 weeks
The change in anterior-posterior centre of pressure displacement from baseline to 6 months post-ACL reconstruction, measured when performing a 10 second standing balance task.
Baseline, 6 months
The change in time taken to complete a sit-to-stand task, from baseline to 6 weeks post-ACL reconstruction
Baseline, 6 weeks
The change in time taken to complete a sit-to-stand task, from baseline to 6 months post-ACL reconstruction
Baseline, 6 months
Secondary Outcomes (5)
The change in Interleukin-6 obtained from blood samples at baseline to 6 months post-ACL reconstruction
6 months post-ACL reconstruction
The change in Tegner Activity Score from baseline to 6 months post-ACL reconstruction
6 months post-ACL reconstruction
The change in Lysholm Knee Scoring Scale from baseline to 6 months post-ACL reconstruction
6 months post-ACL reconstruction
The change in International Knee Documentation Committee subjective knee evaluation form from baseline to 6 months post-ACL reconstruction
baseline to 6 months post-ACL reconstruction
The difference in bone morphogenetic protein-7 (BMP-7) between smokers and non-smokers who undergo ACL reconstruction
At time of surgery
Study Arms (4)
Operation - No PBI
NO INTERVENTIONPatients requiring operation - baseline PBI data not seen by surgeon
Operation - PBI available
EXPERIMENTALPatients requiring operation - baseline PBI data seen by surgeon pre-operatively
Non-operation
NO INTERVENTIONPatients with ACL rupture not requiring operation
Control
NO INTERVENTIONHealthy age matched volunteers - No operation
Interventions
Surgeon performing ACL repair will have prior knowledge of patients pre-operative PBIs to inform surgical practice
Eligibility Criteria
You may qualify if:
- unilateral ACL rupture
- years old
You may not qualify if:
- combined posterior and ACL rupture
- multi-ligament instability including medial or lateral collateral ligament injury
- other lower limb surgery \<3mths
- current significant acute injury affecting other lower extremity joints, or other relevant neurological or musculoskeletal pathology.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- United Lincolnshire Hospitals NHS Trustlead
- University of Lincolncollaborator
Study Sites (1)
United Lincolnshire Hospitals NHS Trust
Lincoln, Lincolnshire, LN2 5QY, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Prof David Mullineaux, PhD
University of Lincoln
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 23, 2014
First Posted
November 24, 2014
Study Start
January 5, 2015
Primary Completion
May 20, 2022
Study Completion
May 20, 2022
Last Updated
May 27, 2022
Record last verified: 2022-05